Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Zura Bio (ZURAW) Competitors

ZURAW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you be buying Zura Bio stock or one of its competitors? The main competitors of Zura Bio include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Zura Bio compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Zura Bio (NASDAQ:ZURAW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Zura Bio N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
Zura BioN/AN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Zura Bio'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Zura Bio Neutral

Summary

60 Degrees Pharmaceuticals beats Zura Bio on 1 of the 1 factors compared between the two stocks.

How does Zura Bio compare to Alpha Tau Medical?

Zura Bio (NASDAQ:ZURAW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

In the previous week, Zura Bio's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Zura Bio Neutral
Alpha Tau Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zura BioN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Zura BioN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Summary

Zura Bio and Alpha Tau Medical tied by winning 0 of the 0 factors compared between the two stocks.

How does Zura Bio compare to Apollomics?

Zura Bio (NASDAQ:ZURAW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Company Net Margins Return on Equity Return on Assets
Zura BioN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, Zura Bio's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
Zura Bio Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zura BioN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Summary

Apollomics beats Zura Bio on 1 of the 1 factors compared between the two stocks.

How does Zura Bio compare to BioVie?

BioVie (NASDAQ:BIVIW) and Zura Bio (NASDAQ:ZURAW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Zura Bio N/A N/A N/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled Zura Bio'saverage media sentiment score.

Company Overall Sentiment
BioVie Neutral
Zura Bio Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Zura BioN/AN/AN/AN/AN/A

Summary

BioVie and Zura Bio tied by winning 0 of the 0 factors compared between the two stocks.

How does Zura Bio compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Zura Bio (NASDAQ:ZURAW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Zura Bio'saverage media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
Zura Bio Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$14.83KN/AN/AN/AN/A
Zura BioN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Zura Bio N/A N/A N/A

Summary

Cardio Diagnostics beats Zura Bio on 1 of the 1 factors compared between the two stocks.

Get Zura Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZURAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZURAW vs. The Competition

MetricZura BioBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$451.91M$6.25B$11.77B
Dividend YieldN/A3.86%2.74%5.26%
P/E RatioN/A4.1429.2527.07
Price / SalesN/A6,879.71504.6873.47
Price / CashN/A13.1343.3053.90
Price / BookN/A77.749.676.69
Net IncomeN/A-$96.07M$3.55B$332.64M

Zura Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZURAW
Zura Bio
N/A$1.08
flat
N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-0.4%
N/AN/A$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$1.22
+43.5%
N/AN/A$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
-5.1%
N/AN/A$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.35
+2.6%
N/AN/A$0.00N/AN/AN/A

Related Companies and Tools


This page (NASDAQ:ZURAW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners